Medical News

RSS

Apps Genius launches Bed Bug Alert app for Apple iPhones

With bedbug infestations on the rise, Apps Genius the developer and publisher of social games and software applications, recently launched the Bed Bug Alert app for the Apple iPhone and iPod Touch. The Bed Bug Alert app is currently available for $1.99 from the Apple Store.

3 Nov 2010

Working at night and in rotating shifts increase risk of work injury

Canadians who work night and rotating shifts are almost twice as likely to be injured on the job than those working regular day shifts, according to a study by researchers at the University of British Columbia.

3 Nov 2010

BioCryst receives $1.1 million in grants under QTDP program

BioCryst Pharmaceuticals, Inc. today announced that the Company had been awarded $1.1 million in grants under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program to advance the development of the Company's clinical programs for peramivir, BCX4208 and forodesine, as well as the pre-clinical BCX4161 kallikrein inhibitor and JAK inhibitor programs.

3 Nov 2010

Immunomedics product candidates, technologies receive recognition from QTDP program

Immunomedics, Inc. a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that all 12 applications from the Company were certified by the Internal Revenue Service of the Department of Treasury as qualified investments in accordance with the Qualifying Therapeutic Discovery Project (QTDP) program under section 48D of the Internal Revenue Code. As a result, the Company will receive an aggregate cash award of $2.9 million.

3 Nov 2010

NIH awards Nemours/Alfred I. duPont Hospital for Children additional $9.5M research grant

The Center for Pediatric Research (CPR) at the Nemours/Alfred I. duPont Hospital for Children was recently awarded an additional 5-year, $9.5-million Center for Biomedical Research Excellence (COBRE) grant from the National Institutes of Health (NIH), National Center for Research Resources (NCRR). This competitive award will allow Nemours to continue to expand the CPR and support the recruitment of additional faculty to this diverse pediatric clinical and research facility.

3 Nov 2010

CONRAD receives $5 million award from USAID

CONRAD, leaders in reproductive health and HIV prevention research, today announced a $5 million award from the US Agency for International Development (USAID). The grant will fund research and development of vaginal rings that are contraceptive and also prevent HIV and STI infections.

3 Nov 2010

New mouse model confirms mutation of beta-synuclein protein promotes neurodegeneration

A team of scientists from Japan and the University of California, San Diego School of Medicine have created a new mouse model that confirms that mutations of a protein called beta-synuclein promote neurodegeneration. The discovery creates a potential new target for developing treatments of diseases like Parkinson's and Alzheimer's.

3 Nov 2010

CVS Caremark supports FDA pathway for approval of biogeneric options

CVS Caremark reiterated the company's support that the U.S. Food and Drug Administration (FDA) implement regulations necessary to approve biogeneric drugs under the Affordable Care Act. The company's Senior Vice President of Specialty Pharmacy Operations, Scott Reid, testified before the FDA today during a public hearing to address the development of an approval pathway for biosimilar and interchangeable biological products held at the agency's headquarters in Silver Spring, Maryland.

3 Nov 2010

Roux-en-Y gastric bypass surgery effective for morbid obesity

Gastric bypass surgery decreases the preference for sweet-tasting substances in obese rats, a study finding that could help in developing safer treatments for the morbidly obese, according to Penn State College of Medicine researchers.

3 Nov 2010

Researchers discover FoxO1 protein interacts with macrophages to promote inflammatory response

Researchers at the University of California, San Diego School of Medicine have discovered that a multi-tasking protein called FoxO1 has another important but previously unknown function: It directly interacts with macrophages, promoting an inflammatory response that can lead to insulin resistance and diabetes. Contrarily, it also generates a negative feedback loop that can limit damage from excessive inflammation.

3 Nov 2010

Quanterix granted $733,437 under QTDP program for Single Molecule Array platform

Quanterix Corporation, a single molecule technology company focused on developing a next generation diagnostics platform, announced today that it was awarded a total of $733,437 in grants under the Qualifying Therapeutic Discovery Project (QTDP) program. The QTDP program recognized Quanterix's Single Molecule Array (SiMoA™) platform as a promising advance that will improve diagnosis and treatment of disease while reducing healthcare costs.

3 Nov 2010

Drinking beet juice increases blood flow to the brain

Researchers for the first time have shown that drinking beet juice can increase blood flow to the brain in older adults - a finding that could hold great potential for combating the progression of dementia.

3 Nov 2010

Avila presents results of AVL-192 preclinical studies for HCV infection at AASLD Meeting

Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, presented results today of preclinical studies that demonstrate its orally-available targeted covalent drug candidate, AVL-192, achieves superior potency against drug-resistant mutations of the Hepatitis C Virus (HCV). These new data were presented today at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) international meeting in Boston, Massachusetts.

3 Nov 2010

Clinton highlights U.S. commitment to strengthening health systems, food security in Cambodia during Asia-Pacific tour

The U.S. is committed to working "closely together to help meet the challenges facing Cambodia and all of Southeast Asia," Secretary of State Hillary Rodham Clinton pledged Monday during a stop in Cambodia as part of her Asia-Pacific tour, that United Press International reports.

3 Nov 2010

Johns Hopkins assists with establishment of Malaysia's first private graduate medical school and teaching hospital

The Johns Hopkins University, the Johns Hopkins University School of Medicine, Johns Hopkins Medicine International (JHI), the international arm of Johns Hopkins Medicine in Baltimore, USA, and Academic Medical Centre Sdn Bhd, subsidiary of Chase Perdana Sdn Bhd, a Kuala Lumpur-based private development corporation, and an associate company of Turiya Sdn Bhd, have signed an agreement to help Malaysia develop its first fully integrated private four-year graduate medical school and teaching hospital.

3 Nov 2010

Enzon receives $1.2 million in funding under IRS Qualifying Therapeutic Discovery Project program

Enzon Pharmaceuticals, Inc. today announced that it has been awarded $1.2 million in funding under the IRS Qualifying Therapeutic Discovery Project (QTDP) program, which was created by Congress as part of the Patient Protection and Affordable Care Act of 2010.

3 Nov 2010

IRIN examines MSF'S concerns over U.S. food aid for malnourished children under age 2

IRIN examines the recently launched 1,000 Days campaign and concerns expressed by Medecins Sans Frontieres' (MSF) Emi MacLean that most of the $2 billion the U.S. spends on food aid is for corn soya blend, which lacks animal-source food and is not ideal for children under age 2 or children who are moderately malnourished.

3 Nov 2010

ImmunoGen to present clinical data of lead compounds at EORTC-NCI-AACR Symposium

ImmunoGen, Inc. a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that several ImmunoGen poster presentations will be made at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics to be held in Berlin, Germany, November 16-19, 2010.

3 Nov 2010

Hyperion HPN-100 phase III pivotal study for urea cycle disorders meets primary endpoint

Hyperion Therapeutics, Inc. today announced that the Company's phase III pivotal study of glycerol phenylbutyrate (HPN-100), an investigational drug for the treatment of urea cycle disorders (UCDs), met its primary endpoint. The non-inferiority study, conducted under a Special Protocol Assessment (SPA) granted by the U.S. Food and Drug Administration (FDA) in June 2009, evaluated the ammonia control of glycerol phenylbutyrate as compared to sodium phenylbutyrate (BUPHENYL®).

3 Nov 2010

Tests show Haitian cholera strains match ones from South Asia, CDC says

Tests have shown that the strain in Haiti's cholera outbreak is similar to cholera strains found in South Asia, the CDC said on Monday, Agence France-Presse reports (11/1).

3 Nov 2010

Medical News

Apps Genius launches Bed Bug Alert app for Apple iPhones

Working at night and in rotating shifts increase risk of work injury

BioCryst receives $1.1 million in grants under QTDP program

Immunomedics product candidates, technologies receive recognition from QTDP program

NIH awards Nemours/Alfred I. duPont Hospital for Children additional $9.5M research grant

CONRAD receives $5 million award from USAID

New mouse model confirms mutation of beta-synuclein protein promotes neurodegeneration

CVS Caremark supports FDA pathway for approval of biogeneric options

Roux-en-Y gastric bypass surgery effective for morbid obesity

Researchers discover FoxO1 protein interacts with macrophages to promote inflammatory response

Quanterix granted $733,437 under QTDP program for Single Molecule Array platform

Drinking beet juice increases blood flow to the brain

Avila presents results of AVL-192 preclinical studies for HCV infection at AASLD Meeting

Clinton highlights U.S. commitment to strengthening health systems, food security in Cambodia during Asia-Pacific tour

Johns Hopkins assists with establishment of Malaysia's first private graduate medical school and teaching hospital

Enzon receives $1.2 million in funding under IRS Qualifying Therapeutic Discovery Project program

IRIN examines MSF'S concerns over U.S. food aid for malnourished children under age 2

ImmunoGen to present clinical data of lead compounds at EORTC-NCI-AACR Symposium

Hyperion HPN-100 phase III pivotal study for urea cycle disorders meets primary endpoint

Tests show Haitian cholera strains match ones from South Asia, CDC says

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News